Glaxo Smith Kline
Recent News About Glaxo Smith Kline View More
-
Judge won't make Hagens Berman pay for discovery as decades-old birth defects are litigated
PHILADELPHIA – A federal judge in Philadelphia recently denied an attempt on the part of pharmaceutical giant GlaxoSmithKline to reallocate costs and fees incurred through still-pending investigative discovery, to the plaintiffs’ counsel in a thalidomide products injury action.